OBI
NEUTRALOndine Biomedical Sees Growing Adoption of Steriwave Across Surgeries
The healthcare company reports increasing clinical adoption of its antimicrobial therapy Steriwave across a range of surgical specialties in the UK and Canada.
Ondine Biomedical Inc.
14.50GBX
0.00%
Market Cap
64.30M
Volume
10k
7% of avg
P/E Ratio
EPS (TTM)
Beta
0.12
Day Range
0.00p - 0.00p
52 Week Range
0.00p14.50p15.00p
14.50p
Upcoming Events
31 December 2025
Phase 3 clinical trial completion in the US
High Impact Event
Early 2026
Potential FDA approval and commercial launch of nasal photodisinfection therapy in the US
High Impact Event
OBI
NEUTRALOndine Biomedical Expands Steriwave Adoption in Fraser Health Hospitals
The healthcare company announces that two more hospitals in the Fraser Health Authority have adopted its Steriwave nasal photodisinfection product to help reduce surgical site infections.
OBI
NEUTRALOndine Biomedical Appoints Peel Hunt as Broker
The life sciences company has appointed a new broker and joint financial adviser to help expand its shareholder base and strengthen investor support.
OBI
NEUTRALOndine Biomedical Expands Steriwave Adoption in Canada's Private Healthcare Sector
The healthcare technology company announces that a leading Canadian private surgery centre has adopted its Steriwave nasal photodisinfection system as the standard of care for orthopedic and plastic surgeries.
OBI
NEUTRALOndine Biomedical Expands Steriwave Adoption Across British Columbia
The healthcare company's antimicrobial therapy is now the standard of care for major surgeries in a second Canadian health authority.
OBI
NEUTRALOndine Biomedical Expands Steriwave Adoption in Quebec
The healthcare company has announced that a second hospital in Quebec has adopted its Steriwave infection prevention technology as standard of care for orthopedic surgeries.
OBI
NEUTRALUK Doctor Wins Award for NHS Steriwave Innovation
The retailer has announced that a UK doctor has won an award for pioneering the use of the company's Steriwave antimicrobial therapy in the NHS.
OBI
NEUTRALOndine Biomedical's Steriwave Technology Shortlisted for Prestigious NHS Award
The healthcare company's Steriwave technology has been shortlisted for a prestigious NHS patient safety award, recognizing its success in reducing surgical site infections.
OBI
NEUTRALOndine Presents Groundbreaking Findings in Fight Against Superbugs
The life sciences company presents major advancements in the fight against multidrug-resistant pathogens, showcasing the powerful synergy between its photodisinfection technology and existing antimicrobials.
OBI
BADOndine Biomedical Announces Discounted Equity Raise
The life sciences company has announced a discounted equity raise, which is a concerning sign of low investor confidence.